期刊文献+

Vaspin与代谢综合征发病机制的关系 被引量:1

Relationship of vaspin and the pathogenesis of metabolic syndrome
原文传递
导出
摘要 脂肪组织是特殊的内分泌器官,可参与能量代谢并分泌多种细胞及组织因子。Vaspin是一种新发现的内脏脂肪特异性蛋白酶抑制剂,属丝氨酸蛋白酶抑制剂超家族。研究发现,vaspin与代谢综合征的发病机制密切相关。其具有胰岛素增敏作用,可以改善糖耐量,调节糖、脂代谢,在肥胖或肥胖相关的功能失调中可能发挥作用。肥胖时脂肪组织的堆积以及胰岛素敏感性的降低都可能导致vaspin水平增加。 Adipose tissue is a special endocrine organ,which participates in energy metabolism and secretes a variety of cytokines and tissue factors. Vaspin is a newly discovered visceral adipose tissue specific protease inhibitor, and it belongs to the serine protease inhibitor (smpine) superfamily. It has been discovered that vaspin has a very close relationship with the pathogenesis of metabolic syndrome (MS). It can increase insulin sensitivity, improve glucose tolerance and regulate glucose and lipid metabolism. Vaspin may play an important role in obesity or obesity related dysfunction. The accumulation of adipose tissue and the reduction of insulin sensitivity accompanied with obesity may lead to the increase of vaspin.
出处 《国际内分泌代谢杂志》 2011年第4期271-273,共3页 International Journal of Endocrinology and Metabolism
基金 辽宁省科学技术计划项目(2009225029) 辽宁省教育厅科技项目(L2010597)
关键词 VASPIN 胰岛素抵抗 肥胖 代谢综合征 Vaspin Insulin resistance Obesity Metabolic syndrome
  • 相关文献

参考文献1

二级参考文献14

  • 1Tan BK, Heutling D, Chen J, Farhatullah S, Adya R, Keay SD, et al. Mefformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes 2008; 57: 1501-1507. 被引量:1
  • 2Gulcelik NE, Karakaya J, Gedik A, Usman A, Gurlek A. Serum vaspin levels in type 2 diabetic women in relation to microvascular complications. Eur J Endocrinol 2009; 160: 65-70. 被引量:1
  • 3Youn BS, Kloting N, Kratzsch J, Lee N, Park JW, Song ES, et al. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 2008; 57: 372-377. 被引量:1
  • 4Kloting N, Berndt J, Kralisch S, Kovacs E Fasshauer M, Schon MR, et al. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Biophys Res Commun 2006; 339: 430-436. 被引量:1
  • 5Gonzalez-Ortiz M, Martinez-Abundis E. Comparison of several formulas to assess insulin action in the fasting state with the hyperglycemic-hyperinsulinemic clamp technique in healthy individuals. Rev Invest Clin 2003; 55:419-422. 被引量:1
  • 6Bao Y, Lu J, Wang C, Yang M, Li H, Zhang X, et al. Optimal waist circumference cutoffs for abdominal obesity in Chinese. Atherosclerosis 2008; 201: 378-384. 被引量:1
  • 7World Health Organization: definition, diagnosis and classification of diabetes mellitus and its complication. WHO/NCD/NCS 1999: 31-33. (Accessed at http://whqlibdoc. who. int/hq/1999/WHO_NCD_NCS_99. 2.pdj-'). 被引量:1
  • 8WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-163. 被引量:1
  • 9Seeger J, Ziegelmeier M, Bachmann A, Lossner U, Kratzsch J, Bluher M, et al. Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clin Endocrinol Metab 2008; 93: 247-251. 被引量:1
  • 10Alessi MC, Poggi M, Juhan-Vague I. Plasminogen activator inhibitor-1, adipose tissue and insulin resistance. Curr Opin Lipidol 2007; 18: 240-245. 被引量:1

共引文献39

同被引文献17

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部